XML 20 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 23,634 $ 36,665
Marketable investments 26,344 90,217
Accounts receivables, net 24,469 18,715
Inventory 9,976 8,106
Prepaid expenses 8,807 11,804
Other current assets 3,143 7,482
Total current assets 96,373 172,989
Property and equipment, net 51,971 41,325
Operating lease right-of-use assets 86,464 85,173
Intangibles, net 136,902 259,705
Goodwill 80,269 79,525
Equity investments 17,176 51,271
Other assets, net 3,685 4,830
Total assets 472,840 694,818
Current liabilities:    
Accounts payable 47,515 27,414
Accrued payroll and related benefits 7,884 21,503
Accrued expenses and liabilities 58,756 37,975
Accrued legal settlements 174,752  
Current portion of deferred revenue 652 1,108
Current portion of operating lease liabilities 13,880 11,539
Current portion of contingent consideration 397 397
Acquisition consideration 7,800 7,537
Current portion of debt 16,286 31,980
Total current liabilities 327,922 139,453
Long-term debt, net of discount 19,130 110,627
Deferred tax liabilities, net 591 2,426
Deferred revenue 7,098 118,942
Derivative liabilities 300 35,700
Operating lease liabilities 85,208 83,431
Contingent consideration 48,949 124,349
Other long-term liabilities 5,311 1,761
Total liabilities 494,509 616,689
Commitments and contingencies (Note 11)
Sorrento Therapeutics, Inc. equity (deficit)    
Common stock, $0.0001 par value; 750,000,000 shares authorized and 522,817,137 and 314,573,225 shares issued and outstanding at December 31, 2022 and 2021, respectively 52 32
Additional paid-in capital 1,988,753 1,513,758
Accumulated other comprehensive income 1,501 1,026
Accumulated deficit (1,959,447) (1,386,604)
Treasury stock, 7,568,182 shares at cost at December 31, 2022 and 2021 (49,464) (49,464)
Total Sorrento Therapeutics, Inc. stockholders' equity (deficit) (18,605) 78,748
Noncontrolling interests (3,064) (619)
Total equity (deficit) (21,669) 78,129
Total liabilities and equity (deficit) $ 472,840 $ 694,818